Who invested in Cour Pharmaceuticals Development?
Cour Pharmaceuticals Development's investors include Alpha Wave Global.
United States · Series A startup
3 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$106Mraised across 3 rounds since 2013, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding recordSEC filing: $500K sold, first sale Aug 2014
No investor was named in the report.
Reported by sec.govSEC filing: $17K sold, first sale Apr 2013
Cour Pharmaceuticals Development's investors include Alpha Wave Global.
Cour Pharmaceuticals Development has raised $106M across 3 rounds since 2013.
Cour Pharmaceuticals Development's most recent round was a Series A of $105M in Jan 2024.
Its most recent round, $105M in Jan 2024, is also its largest on record.
Cour Pharmaceuticals Development's first round on record, in Jan 2024, was backed by Alpha Wave Global.
Cour Pharmaceuticals Development's latest named round is a Series A, in Jan 2024.
Cour Pharmaceuticals Development is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.